SEOUL (Reuters) - South Korean has begun a review of Johnson & Johnson's coronavirus vaccine after the U.S. pharmaceutical firm submitted an application for approval, the government said on Saturday.
The food and drug safety ministry said it would study the one-shot vaccine with private advisory panels before it authorises the vaccine.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!